Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 221

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 221
---
 | $       | - |     | $       | 640,830 |     | $     | 640,830 |
| Total                  |     | $                 | - |     | $       | - |     | $       | 640,830 |     | $     | 640,830 |

|                        |     | December 31, 2023 |   |     |         |   |     |         |           |     |       |           |
|:-----------------------|:----|:------------------|:--|:----|:--------|:--|:----|:--------|----------:|:----|:------|----------:|
|                        |     | Level 1           |   |     | Level 2 |   |     | Level 3 |           |     | Total |           |
| Liabilities:           |     |                   |   |     |         |   |     |         |           |     |       |           |
| Derivative Liabilities |     | $                 | - |     | $       | - |     | $       | 2,306,796 |     | $     | 2,306,796 |
| Total                  |     | $                 | - |     | $       | - |     | $       | 2,306,796 |     | $     | 2,306,796 |

There were no transfers of financial instruments between Level 1, Level 2, and Level 3 during the periods presented. However, certain liabilities measured at fair value and using Level 3 inputs were extinguished during the year ended December 31, 2023. A rollforward of liabilities measured at fair value using Level 3 inputs outstanding during the years ended December 31, 2024 and 2023 are presented in Notes 7 (Debt) and 8 (Derivative Liabilities).

Assets and Liabilities Not Measured at Fair Value on a Recurring Basis

In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company also measures certain assets and liabilities at fair value on a nonrecurring basis. The Company’s non-financial assets, including Intangible Assets and Property and Equipment, are measured at fair value when there is an indication of impairment and the carrying amount exceeds the asset’s projected undiscounted cash flows. These assets are recorded at fair value only when an impairment charge is recognized.

As of December 31, 2024 and